Benign recurrent intrahepatic cholestasis with secondary renal impairment treated with extracorporeal albumin dialysis

被引:13
作者
Saich, R [1 ]
Collins, P [1 ]
Ala, A [1 ]
Standish, R [1 ]
Hodgson, H [1 ]
机构
[1] UCL Royal Free & Univ Coll Med Sch, Ctr Hepatol, Dept Med, London NW3 2PF, England
关键词
recurrent benign intrahepatic cholestasis (BRIC); extracorporeal albumin dialysis (MARS); acute renal failure; cholestasis;
D O I
10.1097/00042737-200505000-00018
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Benign recurrent intrahepatic cholestasis (BRIC) is a rare autosomal recessive condition characterized by intermittent episodes of pruritis and jaundice that may last days to months. Treatment is often ineffective and symptoms, particularly pruritis, can be severe. Extracorporeal albumin dialysis (molecular adsorbent recycling system, MARS) is a novel treatment which removes albumin bound toxins including bilirubin and bile salts. We describe a case of a 34-year-old man with BRIC and secondary renal impairment who, having failed standard medical therapy, was treated with MARS. The treatment immediately improved his symptoms, renal and liver function tests and appeared to terminate the episode of cholestasis. We conclude that MARS is a safe and effective treatment for BRIC with associated renal impairment. (c) 2005 Lippincott Williams & Wilkins.
引用
收藏
页码:585 / 588
页数:4
相关论文
共 26 条
[1]   BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS - A REPORT OF 26 CASES [J].
BRENARD, R ;
GEUBEL, AP ;
BENHAMOU, JP .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1989, 11 (05) :546-551
[2]   A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis [J].
Bull, LN ;
van Eijk, MJT ;
Pawlikowska, L ;
DeYoung, JA ;
Juijn, JA ;
Liao, M ;
Klomp, LWJ ;
Lomri, N ;
Berger, R ;
Scharschmidt, BF ;
Knisely, AS ;
Houwen, RHJ ;
Freimer, NB .
NATURE GENETICS, 1998, 18 (03) :219-224
[3]   Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of γ-glutamyl transpeptidase [J].
Cançado, ELR ;
Leitao, RMC ;
Carrilho, FJ ;
Laudanna, AA .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (09) :1510-1517
[4]  
Cavestro Giulia Martina, 2002, Acta Biomed, V73, P53
[5]  
COHEN J, 1985, LATINOAMERICANA, V15, P113
[6]  
DEPAGTER AGF, 1976, GASTROENTEROLOGY, V71, P202
[7]  
Di Campli C, 2003, CURR MED CHEM, V10, P341
[8]   FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte [J].
Eppens, EF ;
van Mil, SWC ;
de Vree, JM ;
Mok, KS ;
Juijn, JA ;
Elferink, RPJO ;
Berger, R ;
Houwen, RHJ ;
Klomp, LWJ .
JOURNAL OF HEPATOLOGY, 2001, 35 (04) :436-443
[9]   Review of methods to remove protein-bound substances in liver failure [J].
Hughes, RD .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2002, 25 (10) :911-917
[10]  
LOVISETTO P, 1990, RES CLIN LAB, V20, P19